Showing results (61-70 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|August 13, 2010
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancerEleni G Iliopoulou, Panteleimon Kountourakis, Michalis V Karamouzis, et al.Cancer Immunology, Immunotherapy : CII|September 18, 2010
Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markersLei Wu, Anastasia Parton, Ling Lu, et al.Cancer Immunology, Immunotherapy : CII|September 18, 2010
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cellsMax Warncke, Maike Buchner, Gudrun Thaller, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2011
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccineElizabeth A Vasievich, Weihsu Chen, Leaf HuangCancer Immunology, Immunotherapy : CII|January 1, 1990
Induction of antitumor activity in macrophages by mycoplasmas in concert with interferonK Uno, M Takema, S Hidaka, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon gammaH M Blottiere, J Y Douillard, H Koprowski, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing miceT Itoh, Y Sakata, Y Yoshida, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2010
Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challengesMadhav V Dhodapkar, Kavita M DhodapkarCancer Immunology, Immunotherapy : CII|January 18, 2011
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsEmilie P Buddingh, Marco W Schilham, S Eriaty N Ruslan, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2011
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCCChristina Battke, Romana Ruiss, Ulrich Welsch, et al.Pageof 650